Kv1.3-selective blockers are effective at reducing disease severity in multiple animal models of autoimmunity, including in the pristane-induced arthritis (PIA) model of RA, without affecting the clearance of acute infections [6, 7, 9, 10]. This evidence concerns the gene KCNA3 and Arthritis.